Next Article in Journal
Immunotherapy with an HIV-DNA Vaccine in Children and Adults
Next Article in Special Issue
Doubly Phosphorylated Peptide Vaccines to Protect Transgenic P301S Mice against Alzheimer’s Disease Like Tau Aggregation
Previous Article in Journal / Special Issue
Peptide Dose and/or Structure in Vaccines as a Determinant of T Cell Responses
Review

Strategy for Designing a Synthetic Tumor Vaccine: Multi-Component, Multivalency and Antigen Modification

Department of Chemistry, Key Laboratory of Bioorganic Phosphorus Chemistry & Chemical Biology (Ministry of Education), Tsinghua University, Beijing 100084, China
*
Author to whom correspondence should be addressed.
Vaccines 2014, 2(3), 549-562; https://doi.org/10.3390/vaccines2030549
Received: 25 March 2014 / Revised: 30 May 2014 / Accepted: 4 June 2014 / Published: 15 July 2014
(This article belongs to the Special Issue Peptide Vaccine)
Synthetic tumor vaccines have been proven to be promising for cancer immunotherapy. However, the limitation of the specificity and efficiency of the synthetic tumor vaccines need further improvements. To overcome these difficulties, additional tumor-associated targets need to be identified, and optimized structural designs of vaccines need to be elaborated. In this review, we summarized the main strategies pursued in the design of synthetic tumor vaccines, such as multi-component, multivalency, antigen modification and other possible ways to improve the efficiency of synthetic tumor vaccines. View Full-Text
Keywords: tumor; vaccine; multi-component; multivalency; nano-size tumor; vaccine; multi-component; multivalency; nano-size
Show Figures

Figure 1

MDPI and ACS Style

Huang, Z.-H.; Sun, Z.-Y.; Gao, Y.; Chen, P.-G.; Liu, Y.-F.; Chen, Y.-X.; Li, Y.-M. Strategy for Designing a Synthetic Tumor Vaccine: Multi-Component, Multivalency and Antigen Modification. Vaccines 2014, 2, 549-562. https://doi.org/10.3390/vaccines2030549

AMA Style

Huang Z-H, Sun Z-Y, Gao Y, Chen P-G, Liu Y-F, Chen Y-X, Li Y-M. Strategy for Designing a Synthetic Tumor Vaccine: Multi-Component, Multivalency and Antigen Modification. Vaccines. 2014; 2(3):549-562. https://doi.org/10.3390/vaccines2030549

Chicago/Turabian Style

Huang, Zhi-Hua, Zhan-Yi Sun, Yue Gao, Pu-Guang Chen, Yan-Fang Liu, Yong-Xiang Chen, and Yan-Mei Li. 2014. "Strategy for Designing a Synthetic Tumor Vaccine: Multi-Component, Multivalency and Antigen Modification" Vaccines 2, no. 3: 549-562. https://doi.org/10.3390/vaccines2030549

Find Other Styles

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Back to TopTop